Beta1-Blocker Therapy in Traumatic Brain Injury: a Real World Study

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100043098

Enrollment

Unknown

Registered

2021-02-05

Start date

2021-02-01

Completion date

Unknown

Last updated

2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury

Interventions

ß1+:using ß1-Blocker

ß1-:no beta1-blocker

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Admission to the hospital within 72 hours of onset, the main diagnosis is a TBI patien; 2.Get consent from family members.

Exclusion criteria

Exclusion criteria: 1.Unstable vital signs; 2.patients with multiple injuries; 3.family members disagree

Design outcomes

Primary

Measure	Time frame
Heart rate variability;Blood pressure variability;GOS-E at discharge;GOS-E at 3 months;NICU days;Mortality;complication;ISS;GCS;catecholamine;	—

Countries

China

Contacts

Public ContactYuping Li

Northern Jiangsu People's Hospital

liyuping2011@163.com+86 18051062519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026